Long-term Cardiovascular Risk in Cured Cushing's Patients
Terminated
- Conditions
- Cushing's Disease
- Registration Number
- NCT00881283
- Lead Sponsor
- Massachusetts General Hospital
- Brief Summary
The purpose of this study is to determine whether subjects who have been affected by Cushing's disease in the past maintain some different characteristics compared with subjects who have never been diagnosed with the disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 1
Inclusion Criteria
- patients who have been cured of Cushing's disease at least 5 years ago.
Exclusion Criteria
- patients who have been cured of Cushing's disease more than 15 years ago.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method adipokine measurements baseline
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What role do adipokines play in long-term cardiovascular risk for cured Cushing's disease patients?
How do cured Cushing's disease patients compare to healthy controls in terms of metabolic syndrome markers?
What are the key biomarkers associated with residual cardiovascular risk in post-Cushing's disease individuals?
Are there specific molecular pathways linking cortisol excess to chronic cardiovascular complications in Cushing's survivors?
What management strategies reduce cardiovascular risk in patients post-hypothalamic-pituitary-adrenal axis recovery from Cushing's disease?
Trial Locations
- Locations (1)
Neuroendocrine Clinical Center
🇺🇸Boston, Massachusetts, United States
Neuroendocrine Clinical Center🇺🇸Boston, Massachusetts, United States